Revolade NZ DS

revolade   Dan revolade

Revolade 50 Tablet Information Revolade 50 Tablet is a commercial drug that is prescribed in the form of Tablet It is primarily used for the treatment of

Initial dose regimen: Adults: Revolade should be initiated at a dose of 25 mg once daily For chronic HCV patients of East-Southeast-Asian ancestry, Revolade Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments

rummy wilth Revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia lasting 6 months or longer from Revolade 50 Tablet is used to prevent or lower the risk of bleeding in patients with chronic immune thrombocytopenic purpura